Skip to main content
. 2018 May 31;24(5):323–331. doi: 10.1177/1753425918777598

Figure 1.

Figure 1.

The Aa following Pam2Cys determines the cross-priming activity in bone marrow–derived DC (BMDC). (a) and (b) BMDCs were stimulated with Pam2LPs in the presence of OVA. Carboxyfluorescein diacetate succinimidyl ester (CFSE)-labelled OT-I cells were co-cultured with the BMDCs. After 60 h, the degree of OT-I proliferation was assessed by flow cytometry. (a) OT-I cells were gated as CD8α+ TCR Vβ5.1,5.2+ population. The histograms of representative samples are shown. (b) The result including all samples is shown. The results are representative of two independent experiments.